Overview

Effect of the Enteric Hormone Glucagon-Like Peptide (GLP-2) on the Intestinal Blood Flow in Patients With Short Bowel Syndrome

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The aim of the study is to investigate the effect of the enteric hormone Glucagon-like Peptide (GLP-2) on patients with short bowel syndrome
Phase:
N/A
Details
Lead Sponsor:
Glostrup University Hospital, Copenhagen
Treatments:
Glucagon
Glucagon-Like Peptide 1